+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Viral Vector & Plasmid DNA Manufacturing Market - Global Forecast 2026-2032- Product Image
Viral Vector & Plasmid DNA Manufacturing Market - Global Forecast 2026-2032- Product Image
New

Viral Vector & Plasmid DNA Manufacturing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 181 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4986033
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The viral vector and plasmid DNA manufacturing market is evolving rapidly as technological advancements redefine expectations for scalability, compliance, and speed to market. Senior leaders navigating this field face growing pressure to optimize operations and strategy in line with emerging trends, regulatory shifts, and the accelerating pace of innovation.

Market Snapshot: Viral Vector & Plasmid DNA Manufacturing

Between 2025 and 2026, the viral vector and plasmid DNA manufacturing market is projected to expand from USD 5.24 billion to USD 6.10 billion, reflecting a compound annual growth rate (CAGR) of 16.91%. By 2032, the market size is forecast to reach USD 15.67 billion, driven by ongoing integration of these technologies into new biologics and advanced therapeutic pipelines. Growth reflects sustained investment, expanding clinical applications, and rising demand for scalable gene delivery solutions across global biotech landscapes.

Scope & Segmentation of the Viral Vector & Plasmid DNA Manufacturing Market

  • Product Types: Includes plasmid DNA and viral vectors such as adeno-associated, adenoviral, herpes simplex virus, lentiviral, and retroviral formats, addressing diverse gene delivery objectives.
  • Service Models: Analytical testing, full-cycle manufacturing, process development, and regulatory or CMC support ensure production scalability and compliance readiness. Process development covers upstream and downstream optimization, scale-up, technology transfer, and formulation adaptation.
  • Workflow Stages: Key steps encompass upstream processing (cell expansion, transfection or transduction), downstream processing (capture, purification, clarification, polishing), and post-production tasks such as fill and finish, release, and stability testing.
  • Production Platforms: Utilizes bacterial, cell-free, insect, mammalian, and yeast systems, each presenting unique implications for throughput, impurity management, and validation procedures.
  • Bioprocess Modes: Batch, fed-batch, and perfusion processes enable flexibility, suited for both adherent and suspension-based cultures to address different scale and regulatory needs.
  • Manufacturing Models: Options for in-house and outsourced manufacturing (CDMO) deliver strategic flexibility regarding investment, technical capabilities, and speed to market.
  • End-User Categories: Serves biopharma, contract development and manufacturing organizations (CDMOs), contract research organizations (CROs), and research institutes focused on innovative research, development, and supply solutions.
  • Applications: Technologies benefit cell therapy, gene editing, gene therapy, oncolytic virotherapy, vaccine development, and research and development (R&D), enabling advancements in modern medicine.
  • Disease Areas: Main focuses include oncology, rare genetic disorders, neurology, infectious diseases, metabolic, hepatic, cardiovascular, musculoskeletal, and ophthalmology segments.
  • Regions: The Americas, EMEA, and Asia-Pacific each contribute to distinctive market trends, regulatory requirements, and investment patterns.

Key Takeaways for Senior Decision-Makers

  • Organizations are increasingly shifting from traditional laboratory processes to modular technologies and single-use systems, optimizing flexibility and minimizing cross-contamination risk.
  • Combining process development with regulatory expertise streamlines the transition from research through to clinical manufacturing, reducing operational complexity at key handoff points.
  • Vendor diversification strategies and rigorous qualification standards play a key role in addressing supply chain vulnerabilities and potential material shortages.
  • Localization of supply networks and regional investment are gaining momentum, especially as organizations adapt sourcing strategies to dynamic global trade policies and tariff-related uncertainty.
  • Integrating robust analytical and stability assessment early in development supports regulatory compliance and shortens overall cycle times.
  • Collaborative partnership models facilitate access to technical and regulatory expertise while balancing innovation ownership and long-term reliability.

Tariff Impact and Trade Policy Considerations

Ongoing fluctuations in global tariffs significantly impact the cost structure and procurement strategies for critical manufacturing inputs across biologics production, including raw materials and single-use equipment. These challenges are prompting organizations to reevaluate supplier agreements, prioritize sourcing from local partners, and increase their focus on regional manufacturing infrastructure investments. As trade policies continue to shift, thorough vendor vetting and comprehensive documentation are required to meet both regulatory obligations and market demands, ensuring uninterrupted value chain performance.

Methodology & Data Sources

This analysis applies a mixed-methods framework, combining data from peer-reviewed literature, regulatory materials, and technology briefings, with structured interviews conducted among experts in process development, quality assurance, regulation, and commercialization. Findings have been triangulated and validated to present operationally relevant and reliable insights for decision-makers.

Why This Report Matters

  • Enables executive benchmarking of operations and strategic priorities against industry best practices in viral vector and plasmid DNA manufacturing.
  • Informs planning for supply chain adaptation, technology integration, and alignment with evolving regulatory frameworks affecting both service and product models.
  • Delivers an integrated view of risks, segmentation, and regional market strengths, enhancing resource allocation and competitive positioning decisions.

Conclusion

Rapid advancements in science and biomanufacturing reinforce the need for operational agility and supply chain resilience. Forward-looking organizations are well positioned to leverage these strengths, driving biopharma innovation and ensuring sustainable growth within the evolving viral vector and plasmid DNA manufacturing landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Viral Vector & Plasmid DNA Manufacturing Market, by Product Type
8.1. Plasmid DNA
8.2. Viral Vector
8.2.1. Adeno-Associated Viral Vectors
8.2.2. Adenoviral Vectors
8.2.3. Herpes Simplex Virus (HSV) Vectors
8.2.4. Lentiviral Vectors
8.2.5. Retroviral Vectors
9. Viral Vector & Plasmid DNA Manufacturing Market, by Service Type
9.1. Analytical Testing
9.2. Manufacturing
9.3. Process Development
9.3.1. Downstream Optimization
9.3.2. Formulation Development
9.3.3. Scale-Up/Technology Transfer
9.3.4. Upstream Optimization
9.4. Regulatory & CMC Support
10. Viral Vector & Plasmid DNA Manufacturing Market, by Workflow Stage
10.1. Downstream Processing
10.1.1. Capture
10.1.2. Clarification
10.1.3. Concentration/Buffer Exchange
10.1.4. Intermediate Purification
10.1.5. Polishing
10.2. Fill & Finish
10.3. Release & Stability Testing
10.4. Upstream Processing
10.4.1. Bioreactor Production
10.4.2. Cell Expansion
10.4.3. Transfection/Transduction
11. Viral Vector & Plasmid DNA Manufacturing Market, by Production Platform
11.1. Bacterial
11.2. Cell-Free Systems
11.3. Insect
11.4. Mammalian
11.5. Yeast
12. Viral Vector & Plasmid DNA Manufacturing Market, by Bioprocess Mode
12.1. Batch
12.2. Culture Format
12.2.1. Adherent
12.2.2. Suspension
12.3. Fed-Batch
12.4. Perfusion
13. Viral Vector & Plasmid DNA Manufacturing Market, by Source
13.1. In-House Manufacturing
13.2. Outsourced/CDMO
14. Viral Vector & Plasmid DNA Manufacturing Market, by Application
14.1. Cell Therapy
14.2. Gene Editing
14.3. Gene Therapy
14.4. Oncolytic Virotherapy
14.5. Research & Developement
14.6. Vaccine Development
15. Viral Vector & Plasmid DNA Manufacturing Market, by End User
15.1. Biopharmaceutical Companies
15.2. Contract Development & Manufacturing Organizations (CDMOs)
15.3. Contract Research Organizations (CROs)
15.4. Research Institutions
16. Viral Vector & Plasmid DNA Manufacturing Market, by Disease Area
16.1. Cardiovascular
16.2. Hepatic Diseases
16.3. Infectious Diseases
16.4. Metabolic/Endocrine
16.5. Musculoskeletal
16.6. Neurology
16.7. Oncology
16.8. Ophthalmology
16.9. Rare Genetic Disorders
17. Viral Vector & Plasmid DNA Manufacturing Market, by Region
17.1. Americas
17.1.1. North America
17.1.2. Latin America
17.2. Europe, Middle East & Africa
17.2.1. Europe
17.2.2. Middle East
17.2.3. Africa
17.3. Asia-Pacific
18. Viral Vector & Plasmid DNA Manufacturing Market, by Group
18.1. ASEAN
18.2. GCC
18.3. European Union
18.4. BRICS
18.5. G7
18.6. NATO
19. Viral Vector & Plasmid DNA Manufacturing Market, by Country
19.1. United States
19.2. Canada
19.3. Mexico
19.4. Brazil
19.5. United Kingdom
19.6. Germany
19.7. France
19.8. Russia
19.9. Italy
19.10. Spain
19.11. China
19.12. India
19.13. Japan
19.14. Australia
19.15. South Korea
20. United States Viral Vector & Plasmid DNA Manufacturing Market
21. China Viral Vector & Plasmid DNA Manufacturing Market
22. Competitive Landscape
22.1. Market Concentration Analysis, 2025
22.1.1. Concentration Ratio (CR)
22.1.2. Herfindahl Hirschman Index (HHI)
22.2. Recent Developments & Impact Analysis, 2025
22.3. Product Portfolio Analysis, 2025
22.4. Benchmarking Analysis, 2025
22.5. Advanced BioScience Laboratories, Inc.
22.6. Akron Biotech
22.7. Aldevron, LLC
22.8. Avid Bioservices, Inc.
22.9. Batavia Biosciences B.V.
22.10. BioNTech IMFS GmbH
22.11. BioSpace, Inc.
22.12. Biovian Oy
22.13. c-LEcta GmbH
22.14. Catalent, Inc.
22.15. Charles River Laboratories International, Inc.
22.16. Creative Biogene
22.17. Cytiva by Danaher Corporation
22.18. FILTROX AG
22.19. Forge Biologics By Ajinomoto Co., Inc.
22.20. FUJIFILM Diosynth Biotechnologies Inc.
22.21. GE HealthCare Technologies, Inc.
22.22. Genentech, Inc.
22.23. GeneOne Life Science, Inc.
22.24. Genezen Laboratories, Inc.
22.25. GenScript Biotech Corporation
22.26. Hillgene Biopharma Co., Ltd.
22.27. Kaneka Eurogentec S.A.
22.28. Lonza Group Ltd.
22.29. Merck KGaA
22.30. Miltenyi Biotec B.V. & Co. KG
22.31. Oxford Biomedica plc
22.32. POLYPLUS TRANSFECTION S.A.
22.33. REGENXBIO Inc.
22.34. Revvity, Inc.
22.35. Takara Bio Inc.
22.36. Thermo Fisher Scientific Inc.
22.37. Twist Bioscience Corporation
22.38. uniQure N.V.
22.39. Wuxi AppTec Co., Ltd.
List of Figures
FIGURE 1. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCTION PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOPROCESS MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DISEASE AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 15. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 17. CHINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PLASMID DNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PLASMID DNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PLASMID DNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VIRAL VECTOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VIRAL VECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENO-ASSOCIATED VIRAL VECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENO-ASSOCIATED VIRAL VECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENO-ASSOCIATED VIRAL VECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENOVIRAL VECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENOVIRAL VECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENOVIRAL VECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY HERPES SIMPLEX VIRUS (HSV) VECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY HERPES SIMPLEX VIRUS (HSV) VECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY HERPES SIMPLEX VIRUS (HSV) VECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY LENTIVIRAL VECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY LENTIVIRAL VECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY LENTIVIRAL VECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RETROVIRAL VECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RETROVIRAL VECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RETROVIRAL VECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE-UP/TECHNOLOGY TRANSFER, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE-UP/TECHNOLOGY TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE-UP/TECHNOLOGY TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY REGULATORY & CMC SUPPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY REGULATORY & CMC SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY REGULATORY & CMC SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CAPTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CAPTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CAPTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CLARIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CLARIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CLARIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CONCENTRATION/BUFFER EXCHANGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CONCENTRATION/BUFFER EXCHANGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CONCENTRATION/BUFFER EXCHANGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INTERMEDIATE PURIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INTERMEDIATE PURIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INTERMEDIATE PURIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY POLISHING, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY POLISHING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY POLISHING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FILL & FINISH, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FILL & FINISH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FILL & FINISH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RELEASE & STABILITY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RELEASE & STABILITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RELEASE & STABILITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOREACTOR PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOREACTOR PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOREACTOR PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL EXPANSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL EXPANSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL EXPANSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION/TRANSDUCTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION/TRANSDUCTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION/TRANSDUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCTION PLATFORM, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INSECT, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INSECT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INSECT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY YEAST, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY YEAST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY YEAST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BATCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BATCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BATCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CULTURE FORMAT, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CULTURE FORMAT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CULTURE FORMAT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CULTURE FORMAT, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADHERENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADHERENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADHERENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SUSPENSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SUSPENSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FED-BATCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FED-BATCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FED-BATCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PERFUSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PERFUSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PERFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-HOUSE MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-HOUSE MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-HOUSE MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY OUTSOURCED/CDMO, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY OUTSOURCED/CDMO, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY OUTSOURCED/CDMO, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENE EDITING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENE EDITING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ONCOLYTIC VIROTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ONCOLYTIC VIROTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ONCOLYTIC VIROTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH & DEVELOPEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH & DEVELOPEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH & DEVELOPEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VACCINE DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VACCINE DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS (CDMOS), BY REGION, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS (CDMOS), BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS (CDMOS), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DISEASE AREA, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY HEPATIC DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY HEPATIC DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY HEPATIC DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY METABOLIC/ENDOCRINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY METABOLIC/ENDOCRINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY METABOLIC/ENDOCRINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RARE GENETIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RARE GENETIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RARE GENETIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 194. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 195. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 196. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 197. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 198. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 199. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
TABLE 200. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 201. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 202. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCTION PLATFORM, 2018-2032 (USD MILLION)
TABLE 203. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
TABLE 204. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CULTURE FORMAT, 2018-2032 (USD MILLION)
TABLE 205. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 206. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 207. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 208. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DISEASE AREA, 2018-2032 (USD MILLION)
TABLE 209. NORTH AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. NORTH AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 211. NORTH AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 212. NORTH AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 213. NORTH AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 214. NORTH AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
TABLE 215. NORTH AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 216. NORTH AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 217. NORTH AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCTION PLATFORM, 2018-2032 (USD MILLION)
TABLE 218. NORTH AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
TABLE 219. NORTH AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CULTURE FORMAT, 2018-2032 (USD MILLION)
TABLE 220. NORTH AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 221. NORTH AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 222. NORTH AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 223. NORTH AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DISEASE AREA, 2018-2032 (USD MILLION)
TABLE 224. LATIN AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 225. LATIN AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 226. LATIN AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 227. LATIN AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 228. LATIN AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 229. LATIN AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
TABLE 230. LATIN AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 231. LATIN AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 232. LATIN AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCTION PLATFORM, 2018-2032 (USD MILLION)
TABLE 233. LATIN AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
TABLE 234. LATIN AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CULTURE FORMAT, 2018-2032 (USD MILLION)
TABLE 235. LATIN AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 236. LATIN AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 237. LATIN AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 238. LATIN AMERICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DISEASE AREA, 2018-2032 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCTION PLATFORM, 2018-2032 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CULTURE FORMAT, 2018-2032 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DISEASE AREA, 2018-2032 (USD MILLION)
TABLE 254. EUROPE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 255. EUROPE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 256. EUROPE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VIRAL VECTOR, 2018-2032 (USD MILLION)
TABLE 257. EUROPE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 258. EUROPE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 259. EUROPE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW ST

Companies Mentioned

The key companies profiled in this Viral Vector & Plasmid DNA Manufacturing market report include:
  • Advanced BioScience Laboratories, Inc.
  • Akron Biotech
  • Aldevron, LLC
  • Avid Bioservices, Inc.
  • Batavia Biosciences B.V.
  • BioNTech IMFS GmbH
  • BioSpace, Inc.
  • Biovian Oy
  • c-LEcta GmbH
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • Creative Biogene
  • Cytiva by Danaher Corporation
  • FILTROX AG
  • Forge Biologics By Ajinomoto Co., Inc.
  • FUJIFILM Diosynth Biotechnologies Inc.
  • GE HealthCare Technologies, Inc.
  • Genentech, Inc.
  • GeneOne Life Science, Inc.
  • Genezen Laboratories, Inc.
  • GenScript Biotech Corporation
  • Hillgene Biopharma Co., Ltd.
  • Kaneka Eurogentec S.A.
  • Lonza Group Ltd.
  • Merck KGaA
  • Miltenyi Biotec B.V. & Co. KG
  • Oxford Biomedica plc
  • POLYPLUS TRANSFECTION S.A.
  • REGENXBIO Inc.
  • Revvity, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
  • uniQure N.V.
  • Wuxi AppTec Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages181
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6.1 Billion
Forecasted Market Value ( USD ) by 2032 $ 15.67 Billion
Compound Annual Growth Rate16.9%
Regions CoveredGlobal
No. of Companies Mentioned36

Related Topics

Related Reports

Viral Vectors and Plasmid DNA Manufacturing Market Report 2025 - Product Image

Viral Vectors and Plasmid DNA Manufacturing Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Viral Vectors and Plasmid DNA Market Report 2025 - Product Image

Viral Vectors and Plasmid DNA Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Plasmid Purification Market - Global Strategic Business Report - Product Image

Plasmid Purification Market - Global Strategic Business Report

  • Report
  • 471 Pages
  • Global
From
Viral Vectors & Plasmid DNA Manufacturing Market Report 2025-2035 - Product Image

Viral Vectors & Plasmid DNA Manufacturing Market Report 2025-2035

  • Report
  • 483 Pages
  • Global
From
Viral Vector Manufacturing Market - Global Forecast 2025-2032 - Product Image

Viral Vector Manufacturing Market - Global Forecast 2025-2032

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.